Maynard Um
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Celldex Therapeutics (CLDX)
-
-
-
-
-
-
-
Celldex Therapeutics (CLDX) PT Lowered to $38 at Wells Fargo
-
-
-
-
-
-
-
Celldex Therapeutics (CLDX) PT Lowered to $50 at H.C. Wainwright
-
-
-
-
-
-
-
Oppenheimer on Jasper (JSPR): 'adding cohorts and remains on track to begin a registrational program in CSU with a Ph2b study expected to initiate in 2H25'
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on Celldex Therapeutics (CLDX)
-
-
-
-
-
-
-
Guggenheim on Celldex Therapeutics (CLDX): 'We continue to think today's stock reaction is overdone'
-
-
-
-
-
-
-
Stifel Starts Celldex Therapeutics (CLDX) at Buy
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

